Last reviewed · How we verify

NCT04241991

Photobiomodulation (PBM) Therapy on Muscle Performance in Elderly Women

Completed NA Last updated 27 January 2020
What this trial tests

NA trial testing Active laser in Lasers in 20 participants. Completed in 15 January 2020.

Timeline
1 November 2019
Primary endpoint
15 January 2020
15 January 2020

Quick facts

Lead sponsorUniversidade Norte do Paraná
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designfactorial
Maskingdouble
Primary purposebasic science
Enrollment20
Start date1 November 2019
Primary completion15 January 2020
Estimated completion15 January 2020
Sites1 location across Brazil

Drugs / interventions tested

Conditions studied

Sponsor

Universidade Norte do Paraná

Who can join

Adults 65 to 80, female only, with Lasers or Resistance Training. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The present project aims to investigate the acute and chronic effects of laser photobiomodulation (PBM) at 808 nm on muscle performance in physically active elderly women. The hypothesis of this study is that laser PBM would improve muscle strength (i.e., MVIC and 1RM) and endurance (i.e., repetitions-to-failure, blood lactate levels), functional capacity (i.e., short physical performance battery score), and rating of perceived exertion when compared with placebo laser.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Universidade Norte do Paraná trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04241991.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing